June 13th 2025, 8:00pm
Dr. Aaron Gerds breaks down the outcomes of the phase 3 VERIFY trial, investigating rusfertide, for patients with polycythemia vera, a type of blood cancer.
June 13th 2025, 1:16pm
Dr. Joshua K. Sabari and Dr. Prantesh Jain delve into key lung cancer outcomes from the 2025 ASCO Meeting that patients should be aware of.
June 12th 2025, 8:00pm
Expert oncologists Dr. Joshua K. Sabari and Dr. Eric K. Singhi break down key updates and takeaways in lung cancer treatment following ASCO 2025.
June 12th 2025, 1:00pm
Dr. Michael Serzan provides expert takeaways on treatment updates for patients with early-stage kidney cancer following the 2025 ASCO Meeting.
June 11th 2025, 8:00pm
Dr. Joshua K. Sabari sat down with Dr. Daniel V. Araujo to discuss topline takeaways from the 2025 ASCO Meeting across the realm of genitourinary oncology
June 11th 2025, 1:00pm
Patients can prepare for self-advocacy by bringing personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner.
June 10th 2025, 8:00pm
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
June 10th 2025, 1:00pm
The VERIFY trial explores rusfertide to manage polycythemia vera without causing iron deficiency symptoms, Dr. Aaron Gerds explained.
June 9th 2025, 8:00pm
Michelle Kirschner discusses the how patients can foster a strong network of supporters from diagnosis through survivorship.
June 9th 2025, 1:28pm
It is important to understand why it is vital that patients and survivors of cancer take steps to reduce the body’s burden both before and after treatment.
What the Changing Seasons Taught Me About Cancer and Life
Understanding the Importance of Biomarker Testing in Lung Cancer
How to Individually Tailor Myelofibrosis Treatment Options
A Day in the Life of a Breast Cancer Survivor